Assessment of Maternal Hematological and Biochemical Parameters in Pregnancy Outcome: A Clinical Study

  • Anjali Agarwal Principle Specialist, Department of Obstetrics & Gynaecology, District Hospital Dhouipur, Rajasthan, India
  • Mahavir Prasad Agarwal MD (Pathology & Microbiology), District Hospital, Dhoulpur, Rajasthan, India.
Keywords: Biochemical, Hematological, Pregnancy.


Background: Medical conditions like eclampsia, hemorrhage- ante or post-partum have increased the occurrence of maternal deaths.  Pre-eclampsia can cause potentially lethal events like abruption of placenta, DIC, hemorrhage, liver failure, kidney failure and cardiovascular failure.  Therefore, the present study was aimed to estimate the effect of maternal Hematological and Biochemical Parameters in Pregnancy Outcome. Methods: The study consisted of all the pregnant females reporting to the hospital during a duration of 2 years.  The females with systolic pressure above 140 mmHg and diastolic pressure above 90 mm Hg were regarded as hypertensive and included in the study. All the required hematological and biochemical markers like AST, ALT, hemoglobin, PCV, Uric acid, MCV and red blood cell, prothrombin time and platelet counts were evaluated. A follow up of all the subjects were maintained during the entire pregnancy duration and outcome was noted. All the data obtained was arranged in a tabulated form and analyzed using SPSS software. Student t test was used for analysis and probability value of less than 0.05 was considered as significant.

Results: The mean age of the subjects was 29.34+/-3.20 years. The mean hemoglobin level amongst subjects who died was 12.55 +/-1.67 and amongst the Live subjects was 13.44 +/-1.82. The mean ALT level amongst subjects who died was 163.76±342.7 and amongst the Live subjects was 45.47±55.23. There was a significant difference between them. The mean AST was 324.68±800.18 amongst dead mothers and 50.43±143.17 amongst live mothers.

Conclusion: From the above study it can be concluded that biochemical parameters act as valuable predictors of pregnancy outcome. AST, ALT and uric acid levels were significantly different amongst both the groups.


Download data is not yet available.


1. Datta D, Datta PP. Maternal Mortality In India: Problems and Strategies. Asian Journal of Medical Research. 2013; 2(1): 33-35
2. Sibai BM, Gordon T, Thom E. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal – Fetal Medicine Units. Am J Obstet Gynecol. 1995; 172(2): 642-48.
3. LoJo, Mission JF, Caughey AS, Hypertensive disease of pregnancy and maternal mortality. Curr Opin. Obstet Gynecol. 2013 April; 25(2): 124-32.
4. Ghulmiyyah L, Sibai B. Semin Perinatol.Maternal mortality from preeclampsia/ Eclampsia. 2012 Feb; 36(1); 56-9.
5. Dekker GA, Sibai BM. Etiology and Pathogenesis of PE: Current concepts. AM J Obstet Gynecol. 1998; 179(5):1359-75.
6. Kar J, Jina R, Srivastava K, Srivastava R, Mishra RK, Singh VB, et al. Serum magnesium level in normal and abnormal pregnancy. J Obstet Gynecol Ind 2001; 51(4): 38-40.
7. Rana A. Oxidative stress in pregnancy-Role of antioxidants. Obstet Gynaecol Today 2004; 9(12): 810-13.
8. Schiff E, Friedman SA, Stampfer M, Kao L, Pamela RN, Barrett H, et al. Dietary consumption and plasma concentrations of Vitamin E in pregnancies complicated by preeclampsia. Am J Obstet Gynaecol 1996; 175:1024-8.
9. Chaudhari L, Tandon OP, Vaney N, Agarwal N. Lipidperoxidation and antioxidant enzymes in gestational diabetes. Ind J Physiol Pharmacol 2003; 47 (4): 441-46.
10. Jadeja HB, Desai P, Hazra M. Perinatal outcomes in babies born to mothers with abnormally high maternal glucose levels a case controlled prospective study. J Obstet Gynaecol Ind 1993; 43: 20-23.
11. Lancet M, Fisher IL. The value of blood uric acid in toxemia of pregnancy. J Obstet Gynecol. 1956; 63:116-19.
12. Razia Sultana, Selina A, Nasima S, Faziul Ksrim SM, Farhana A. Association of serum uric acid with preeclampsia: A case control study. Delta Med Col J. 2013; 1(2)46-50
13. Hawkins TL, Roberts LM, Brown MA Plasma Uric acid remains a marker of poor outcome in hypertensive pregnancy: a retrospective cohort study. BJOG. 2012; 119(4): 484-92.
14. Purnima Dey S, Jonal S. Evaluation of serum LDH and gamma glutamyl transferase in preeclamptic pregnancy in third trimester. Int J Res Med Sci .2013:1(4) 365-368
15. Qublan HS, Ammarin V, Bataineh O, Al-Shraideh Z, Tahat Y, Awamleh I, Khreisat B, Nussair B and Amarin ZO. “Lactic dehydrogenase as a biochemical marker of adverse pregnancy outcome in severe pre-eclampsia”. Med Sci Monit, 2005; 11(8): 393-397.
16. Dusica Maksmilijan Kocijancic, snenzana P, Darkkoplecan. Correlation of biochemical parameters & neonatal outcome in patients with gestational hypertension. Clinical & experimental hypertension. 2013; 35(1): 6-10.
How to Cite
Agarwal A, Agarwal M. Assessment of Maternal Hematological and Biochemical Parameters in Pregnancy Outcome: A Clinical Study. IABCR [Internet]. 30Sep.2018 [cited 18Oct.2018];4(3):13-5. Available from: